Silverarc Capital Management »

Vaxcyte shares owned by Silverarc Capital Management

Quarter-by-quarter ownership of Vaxcyte (PCVX) shares owned by Silverarc Capital Management from 13F filings

Historical chart of Silverarc Capital Management investment in Vaxcyte

Tip: Access up to 7 years of quarterly data

All positions including Vaxcyte held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaxcyte by Silverarc Capital Management

Quarter filed Position value Share count Share price at filing
2022-12-31 $4.0M 83k 47.95

More positions owned by Silverarc Capital Management

ImmunoGen Long Option Calls Call Option
SPRD S&P Biotech ETF Long Option Calls Call Option (XBI)
Akero Therapeutics Long Option Calls Call Option (AKRO)
Mirati Therapeutics Long Option Calls Call Option
Morphic Holding Equities (MORF)
Merus NV Equities (MRUS)
CymaBay Therapeutics Long Option Calls Call Option
Soleno Therapeutics Equities (SLNO)
Intra-Cellular Therapies Equities (ITCI)
Poseida Therapeutics Equities (PSTX)
Krystal Biotech Equities (KRYS)
Mersana Therapeutics Long Option Calls Call Option (MRSN)
KalVista Pharmaceuticals Long Option Calls Call Option (KALV)
Biogen Idec Equities (BIIB)
Urogen Pharma Equities (URGN)

View all positions for Silverarc Capital Management

Top funds holding Vaxcyte

Vanguard Group
RA Capital Management
Henderson Group
Wellington Management Company
T. Rowe Price Associates
Alliancebernstein
Fred Alger Management
Jennison Associates
Westfield Capital Management Company
Braidwell
Frazier Life Sciences Management
OrbiMed Advisors
Commodore Capital
Perceptive Advisors
Franklin Resources

View all funds holding Vaxcyte